中文摘要：

目的 探讨布洛芬与氨基葡萄糖对膝骨关节炎（OA）滑膜细胞增殖及软骨寡聚基质蛋白（COMP）表达的影响.方法 布洛芬与氨基葡萄糖含药血清培养早期和晚期滑膜细胞,四唑氮化合物/黄嘌呤氧化酶（MTS/PMS）法测定吸光度（A）值,hCOMP定量试剂盒测定COMP含量.采用等方差假设双侧t检验进行统计学处理.结果 通过MTS/PMS法观察确定布洛芬与氨基葡萄糖含药血清培养滑膜细胞观察点在第5～7天;氨基葡萄糖含药血清培养滑膜细胞A值[晚期组（0.054±0.021）,早期组（0.777±0.034）]低于正常血清对照组（P＜0.05）.布洛芬[晚期组（35.4±1.9）,早期组（46.0±2.2）]与氨基葡萄糖含药血清[晚期组（36.6±1.3）,早期组（48.8±1.3）]对软骨寡聚基质蛋白的表达也有明显降低作用（P＜0.05）.结论 氨基葡萄糖可以抑制体外培养早期和晚期膝OA患者滑膜细胞增殖,而布洛芬与氨基葡萄糖皆可抑制体外培养滑膜细胞分泌COMP.

英文摘要：

Objective To compare the effect of ibuprofen and glucosamine on synoviocyte proliferation and cartilage oligomeric matrix protein （COMP） expression in human knee osteoarthritis. Methods Human synoviocytes were isolated from synovium （earlier stage and late stage of OA） by tissue culture and were cocultured with ibuprofen and glucosamine. The concentration of COMP was determined by MTS/PMS method and hCOMP kit. Two-tailed t-test was used for statistical analysis. Results The observation time of tissue culture was determined at 5～7 day by the MTS/PMS method. The A values of glucosamine [ late stage group （0.054±0.021）, early stage group （0.777±0.034）] were less than the normal serum control group （P〈0.05）.Both ibuprofen [late stage group （35.4±1.9）, early stage group （46.0±2.2）] and glucosamine [late stagegroup （36.6±1.3）, early stage group （48.8±1.3） ] could decrease the concentration of COMP in synoviocyte secretion in vitro （P〈0.05）. Conclusion Glucosamine can inhibit the synoviocyte proliferation of human knee osteoarthritis （both early stage and late stage） in vitro. Both ibuprofen and glucosamine can inhibit the COMP secretion of synoviocyte in vitro.